 |
|
|
 |
|
Immune-Boosting Lung Cancer Therapy Shows Promise
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 This study shows that MAGE-A3 ASCI provides benefits similar to chemotherapy with only minimal side effects, such as mild reactions at the injection site and fever within 24 hours of the injection.
"Therefore, it is suitable for long-term maintenance treatment and, for most patients, including older patients or patients in weak physical condition after surgery, allowing them to live a normal life whilst on cancer treatment," Vansteenkiste said.
A Phase III trial of MAGE-A3 ASCI is now under way.
Text Continues Below

More information
The U.S. National Cancer Institute has more about lung cancer.
Page: << Prev | 1 | 2
-- Robert Preidt
|
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 4/25/2008
|
 |

SOURCE: European Society for Medical Oncology, news release, April 25, 2008
|